105 related articles for article (PubMed ID: 8943688)
1. Amplification of ERBB oncogenes in squamous cell carcinomas of the head and neck.
Rodrigo JP; Ramos S; Lazo PS; Alvarez I; Suárez C
Eur J Cancer; 1996 Oct; 32A(11):2004-10. PubMed ID: 8943688
[TBL] [Abstract][Full Text] [Related]
2. Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer.
Reinmuth N; Brandt B; Kunze WP; Junker K; Thomas M; Achatzy R; Scheld HH; Semik M
Eur Respir J; 2000 Nov; 16(5):991-6. PubMed ID: 11153605
[TBL] [Abstract][Full Text] [Related]
3. MYC amplification in squamous cell carcinomas of the head and neck.
Rodrigo JP; Lazo PS; Ramos S; Alvarez I; Suárez C
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):504-7. PubMed ID: 8615967
[TBL] [Abstract][Full Text] [Related]
4. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
[TBL] [Abstract][Full Text] [Related]
5. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in squamous cell carcinomas of the hypopharynx with correlations to clinicopathological features.
Rodrigo JP; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Suárez C
Oral Oncol; 2002 Jun; 38(4):357-63. PubMed ID: 12076699
[TBL] [Abstract][Full Text] [Related]
8. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck.
Ishitoya J; Toriyama M; Oguchi N; Kitamura K; Ohshima M; Asano K; Yamamoto T
Br J Cancer; 1989 Apr; 59(4):559-62. PubMed ID: 2713242
[TBL] [Abstract][Full Text] [Related]
9. Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.
Yin XY; Donovan-Peluso M; Whiteside TL; Johnson JT; Day R; Herberman RB; Locker J
Genes Chromosomes Cancer; 1991 Nov; 3(6):443-54. PubMed ID: 1777414
[TBL] [Abstract][Full Text] [Related]
10. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.
Woelber L; Hess S; Bohlken H; Tennstedt P; Eulenburg C; Simon R; Gieseking F; Jaenicke F; Mahner S; Choschzick M
J Clin Pathol; 2012 Feb; 65(2):133-9. PubMed ID: 22128196
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
12. Variability of genetic alterations in different sites of head and neck cancer.
Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA
Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
[TBL] [Abstract][Full Text] [Related]
13. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
Muller D; Millon R; Velten M; Bronner G; Jung G; Engelmann A; Flesch H; Eber M; Methlin G; Abecassis J
Eur J Cancer; 1997 Nov; 33(13):2203-10. PubMed ID: 9470807
[TBL] [Abstract][Full Text] [Related]
14. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas.
Werkmeister R; Brandt B; Joos U
Oral Oncol; 2000 Jan; 36(1):100-5. PubMed ID: 10889928
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
[TBL] [Abstract][Full Text] [Related]
17. Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck.
Volling P; Jungehülsing M; Jücker M; Stützer H; Diehl V; Tesch H
Eur J Cancer; 1993; 29A(3):383-9. PubMed ID: 8398339
[TBL] [Abstract][Full Text] [Related]
18. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
Field JK; Spandidos DA; Yiagnisis M; Gosney JR; Papadimitriou K; Stell PM
Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
[TBL] [Abstract][Full Text] [Related]
19. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
20. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.
Bei R; Budillon A; Masuelli L; Cereda V; Vitolo D; Di Gennaro E; Ripavecchia V; Palumbo C; Ionna F; Losito S; Modesti A; Kraus MH; Muraro R
J Pathol; 2004 Nov; 204(3):317-25. PubMed ID: 15476268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
